Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Joyner and Jeffrey Winters.
Michael Joyner
Connection Strength
1.147
Jeffrey Winters
  1. Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors. Nat Commun. 2021 08 11; 12(1):4864.
    View in: PubMed
    Score: 0.240
  2. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med. 2021 03 18; 384(11):1015-1027.
    View in: PubMed
    Score: 0.231
  3. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J Clin Invest. 2020 09 01; 130(9):4791-4797.
    View in: PubMed
    Score: 0.225
  4. Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clin Proc. 2020 09; 95(9):1888-1897.
    View in: PubMed
    Score: 0.223
  5. COVID-19 convalescent plasma: Interim recommendations from the AABB. Transfusion. 2021 04; 61(4):1313-1323.
    View in: PubMed
    Score: 0.058
  6. In Reply - Micro-Thrombosis, Perfusion Defects, and Worsening Oxygenation in COVID-19 Patients: A Word of Caution on the Use of Convalescent Plasma. Mayo Clin Proc. 2021 01; 96(1):259-261.
    View in: PubMed
    Score: 0.057
  7. Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors. Mayo Clin Proc. 2020 11; 95(11):2343-2349.
    View in: PubMed
    Score: 0.056
  8. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 06 01; 130(6):2757-2765.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.